🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
The Good Bug raises ₹100 cr to lead gut health revolution in India
Inshorts
·
4m ago
Medial
The Good Bug has raised ₹100 crore in funding led by Susquehanna Asia VC, with continued backing from Fireside Ventures. The funds will fuel R&D, product innovation, and nationwide expansion. With 10 lakh+ users, TGB aims to revolutionise gut health using microbiome science. Its latest GLP-1-based solution tackles obesity and gut issues, strengthening its leadership in India's wellness space.
View Source
1
Related News
Susquehanna Asia VC leads $12-mn funding round in The Good Bug
VCCircle
·
4m ago
Medial
Consumer healthcare startup The Good Bug, focusing on gut health, raised $11.9 million in funding led by Susquehanna Asia VC, with support from existing investors like Fireside Ventures. The funds will advance research in gut bacteria and microbiome science to address health issues such as obesity and women's wellness. Co-founder Keshav Biyani emphasizes the goal of enhancing consumer awareness and product reach across India. The Good Bug, founded in 2022, has over 1 million customers in India.
View Source
The Good Bug raises Rs 100 crore from Susquehanna Asia VC, Fireside
Economic Times
·
4m ago
Medial
Gut health startup The Good Bug raised Rs 100 crore ($12 million) in Series B funding, led by Susquehanna Asia Venture Capital, with Fireside Ventures also participating. Founded in 2022, the Mumbai-based company creates probiotic products for digestion, immunity, and metabolic health. The funds will enhance microbiome R&D, clinical trials, distribution, and brand awareness. Previously, they raised $4 million in 2024. The company recently launched Metabolically Lean, a GLP-1-based weight-loss product.
View Source
The Good Bug raises $3.5 mn in Series A
Livemint
·
1y ago
Medial
The Good Bug, a probiotics brand in India, has raised $3.5 million in a Series A funding round led by Fireside Ventures. The company, founded by Prabhu Karthikeyan and Keshav Biyani, aims to develop new products, expand its team, and invest in brands. It offers USFDA-approved probiotics for various health concerns and has set a target of ₹250 crore ($33.5 million) in revenues within three years. The global digestive health market is projected to reach $104.4 billion by 2032, driving the demand for gut health products.
View Source
Exclusive: The Good Bug Raises $3.5 Mn From Sharrp, Fireside Ventures
Inc42
·
11m ago
Medial
The startup, The Good Bug, has raised INR 20 Cr out of the total INR 30 Cr. The remaining amount is expected to be received soon. The funds will be used to expand the product portfolio of the D2C startup, which specializes in gut health and wellness products. The company was founded in 2022 by Keshav Biyani and Prabhu Karthikeyan.
View Source
India’s probiotics market doubles in 5 years, hits Rs 2,070 cr in 2025
Economic Times
·
3m ago
Medial
India's probiotics market has nearly doubled over five years, expanding from ₹1,016 crore in 2021 to an estimated ₹2,070 crore by 2025, driven by rising consumer demand for gut health solutions and immunity-boosting products. Brands like Amul and Mother Dairy lead the market alongside pharmaceutical giants such as Sun Pharma and Zydus. Despite the robust growth, experts caution against the unwarranted use of probiotics for conditions without proven benefits.
View Source
Gut wellness brand Lifechart raises $500K in seed round
Entrackr
·
11m ago
Medial
Lifechart, a gut wellness brand, has successfully raised $500,000 in a seed funding round. Prajay Advisors LLP contributed $250,000, while the remaining amount came from Agility Ventures, Expert Dojo, and a group of angel investors, including Ahana Gautam, Nitish Mittersain, Sarath Sura, and Marwari Angels, through convertible instruments. Previously, Lifechart secured $200,000 in a pre-seed round in 2022 from Expert Dojo and Nazara Technologies’ Nitish Mittersain. The new funding will enhance Lifechart’s AI capabilities, launch proprietary diagnostic solutions, and develop a brand focused on tier 1 cities, the company said in a press release. Co-founded in 2022 by Mukul Shah and Mansi Sharma, Lifechart aims to tackle the increasing gut health issues in India by offering AI-driven predictive technology and products created by BAMS and BHMS doctors. The brand plans to introduce plant-based microbiome-focused products and comprehensive wellness kits targeting common gut issues like constipation, fatty liver, piles, gas, and acidity. With market research indicating the global gut health market could reach $18 billion by 2025-26, Lifechart’s initiatives position it to capture a significant share. Their predictive AI model aims to tailor services based on demographic and regional health patterns, having already impacted over 250,000 customers primarily in tier II, III, and IV cities.
View Source
Iom Bioworks raises Rs 4 Cr in seed round led by IPV
Entrackr
·
3m ago
Medial
Iom Bioworks, a Bengaluru-based deep science startup focused on personalized microbiome-driven healthcare, has raised Rs 4 crore in its seed round led by Inflection Point Ventures (IPV). The proceeds will be used to strengthen marketing, secure intellectual property, scale up core infrastructure, and expand both scientific and commercial teams. Founded in 2022 by Bipin Pradeep Kumar, Dr. Samik Ghosh, and Dr. Hiroaki Kitano, Iom Bioworks is advancing personalized healthcare by identifying and therapeutically modulating key gut bacteria to enhance human health and well-being. The firm’s proprietary platform combines artificial intelligence with large-scale biological network mapping to deliver food and prebiotic recommendations tailored to individual microbiomes. In its first year, Iom Bioworks claims to have served over 500 customers, secured two patents (with two more in advanced stages), and published its research in leading scientific journals. It operates with pan-India logistics and offers a complete digital experience, including at-home gut profiling kits and personalized wellness plans.
View Source
Lifechart’s Guttify secures $360K from Unichem Labs’ Family Office
Entrackr
·
4m ago
Medial
Lifechart’s Guttify secures $360K from Unichem Labs’ Family Office Lifechart, a health-tech startup focused on gut wellness, has raised $360,000 in an extended seed round for its gut health brand Guttify, led by Prajay Advisors, the family office of the founders of Unichem Labs, Prakash Mody and Jayendra Shah. This $360K raise follows a $500K seed round in October 2024, backed by Expert Dojo, Agility Ventures, Sunn91 Ventures, government seed schemes, and angels like Nitish Mittersain and Ahana Gautam—bringing Lifechart’s total funding to over $1 million. Co-founded in 2022 by Mukul Shah and Mansi Sharma, Guttify is a gut health brand designed for India’s urban population (tier I and III cities), and it adopts a diagnosis-first approach. It offers DIY at-home gut testing kits and clinically validated solutions that combine modern science with herbal methods. Its first product, a pH saliva testing kit for acidity, is already live, with more kits priced as low as Rs 99 set to launch in the coming months. Guttify aims to empower every Indian with accessible, accurate, and personalized gut health solutions—grounded in science, enabled by technology, and inspired by Ayurveda. Lifechart and Guttify aspire to build a full-stack science-backed gut wellness ecosystem to address the urgent and widespread gut health crisis in India. According to market research, the Indian gut wellness market is projected at $18 billion and over 60% of the Indian population suffers from digestive issues.
View Source
Healthtech startup Peping raises $400K led by Better Capital, others
IndianStartupNews
·
1y ago
Medial
Bengaluru-based digital healthcare clinic Peping has secured $400,000 in a funding round led by Better Capital. The startup aims to revolutionize the treatment of gut health issues by providing personalized care plans that consider factors such as lifestyle and test results to address the root causes of health problems. The funds will be used to enhance the platform's product and technology infrastructure and build a team with deep industry knowledge. Peping seeks to establish itself as a leading healthcare provider for digestive health issues in India.
View Source
Iom Bioworks Bags INR 4 Cr in Seed Round to Disrupt Gut Health Science
StartupTalky
·
3m ago
Medial
Iom Bioworks, a Bengaluru-based startup, secured INR 4 crore in seed funding led by Inflection Point Ventures. Dedicated to advancing healthcare through gut microbiome science, the company uses AI and advanced modeling to offer personalized health solutions. The funds will boost marketing, IP rights, infrastructure, and team growth. Founded in 2022, Iom Bioworks has reached 500 users, secured patents, and aims to transform healthcare with its focus on microbiome-driven health and well-being.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
Aug 2025
Jurifly
Build. Comply. Fund. Fly.
FloatFi App
Crypto to INR payments app for Indians
ForkMyCV
Your CV, Done Right.
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in